Xenetic Biosciences stockholders approve director election, auditor ratification, equity plan increase

Xenetic Biosciences, Inc.

All seven director nominees elected; broker non-votes of 4,463,160 for each.
Ratification of Marcum LLP as independent auditor for FY2021 approved: 7,554,719 for, 106,532 against.
Advisory 'say-on-pay' resolution passed: 2,690,613 for, 472,665 against, 106,883 abstentions.
Amendment to Equity Incentive Plan to increase authorized shares by 1,500,000 approved: 2,568,737 for, 670,987 against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.